J.Jill (NYSE:JILL) raised its fourth-quarter and full-year financial guidance on Monday, citing a "stronger-than-anticipated" conclusion to the 2025 holiday season as the retailer prepares for key investor meetings at the ICR Conference.
Zura Bio Limited 9NASDAQ:ZURA) announced it is expanding the patient population for its mid-stage trial of tibulizumab in hidradenitis suppurativa (HS), a move intended to bolster the study’s statistical power as the company prepares for a critical data readout later this year.
Aura Minerals (NASDAQ:AUGO) reported record-breaking preliminary production for the fourth quarter of 2025, bolstered by the successful ramp-up of its Borborema mine and the initial integration of its newest acquisition in Brazil.
Lululemon Athletica (NASDAQ:LULU) raised its fourth-quarter profit and revenue forecasts, signaling that resilient holiday demand for its yoga-inspired apparel is helping the company navigate a cooling U.S. retail environment.
Summit Therapeutics (NASDAQ:SMMT) announced a clinical trial collaboration with GSK (NYSE:GSK) to evaluate the combination of ivonescimab, Summit’s novel investigational PD-1/VEGF bispecific antibody, with risvutatug rezetecan (GSK’227), GSK’s investigational B7-H3-targeting antibody-drug conjugate (ADC), in multiple solid tumor settings, including small cell lung cancer (SCLC).
Bellevue, Washington-based Savers Value Village (NYSE:SVV), a leading operator of for-profit thrift stores focused on second-hand apparel, home goods, and accessories, announced preliminary, unaudited net sales results for the fourteen-week fourth quarter and fifty-three-week fiscal year ended January 3, 2026, in connection with its participation in the ICR Conference January 12-14, 2026.
West Pharmaceutical Services (NYSE:WST), a leading provider of injectable packaging and delivery systems, announced it has entered into a definitive agreement to sell all manufacturing and supply rights for its SmartDose 3.5mL On-Body Delivery System, along with associated facilities, to AbbVie (NYSE:ABBV) for $112.5 million in cash at closing, subject to customary working capital and other adjustments.
Las Vegas-based Allegiant Travel Co. (NASDAQ:ALFT) and Minneapolis-based Sun Country Airlines Holdings (NASDAQ:SNCY) announced Sunday that Allegiant has agreed to acquire Sun Country in an all-cash-and-stock transaction valued at approximately $1.5 billion, marking the latest move in a wave of consolidation among smaller U.S. carriers.
Kyivstar (NASDAQ:KYIV), Ukraine's leading mobile operator and a subsidiary of VEON (NASDAQ:VEON), launched a 5G pilot network in the western city of Lviv on January 12, 2026, in collaboration with the Ministry of Digital Transformation of Ukraine.
Cytek Biosciences (NASDAQ:CTKB), a leading provider of cell analysis solutions including its flagship Aurora and Northern Lights spectral flow cytometry platforms, announced preliminary, unaudited revenue expectations for the fourth quarter and full year ended December 31, 2025.
Zymeworks (NASDAQ:ZYME), a clinical-stage biotechnology company developing novel, bispecific antibody therapeutics, provided a strategic update outlining key priorities for 2026, anchored by recent clinical and regulatory progress for its lead candidate Ziihera (zanidatamab-hrii).
Natera (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, released preliminary unaudited financial and operational results for the fourth quarter and full year ended December 31, 2025.
